gemcitabine has been researched along with Anus Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cleland, LG; Graf, SW; Limaye, VS | 1 |
Bremer, M; Dörk, T; Gross, M; Karstens, JH; Morlot, S; Schindler, D | 1 |
2 other study(ies) available for gemcitabine and Anus Neoplasms
Article | Year |
---|---|
Gemcitabine-induced radiation recall myositis in a patient with dermatomyositis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Dermatomyositis; Female; Gemcitabine; Humans; Immunosuppressive Agents; Lung Neoplasms; Magnetic Resonance Imaging; Myositis; Neoplasms, Multiple Primary; Radiation Injuries; Treatment Outcome | 2014 |
Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Combined Modality Therapy; Cytogenetics; Deoxycytidine; Dose Fractionation, Radiation; Fanconi Anemia; Flow Cytometry; Gemcitabine; Humans; Lymphatic Metastasis; Male; Mouth Neoplasms; Mutation; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Radiation Tolerance; Radioisotope Teletherapy; Radiotherapy Dosage; Salvage Therapy; Time Factors; Tongue Neoplasms | 2003 |